| N04B |
N04B Dopaminergic agents |
| N04BA |
N04BA Dopa and dopa derivatives |
| N04BA01 |
N04BA01 Levodopa |
| N04BA02 |
N04BA02 Levodopa and decarboxylase inhibitor |
| N04BA03 |
N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor |
| N04BA04 |
N04BA04 melevodopa |
| N04BA05 |
N04BA05 melevodopa and decarboxylase inhibitor |
| N04BA06 |
N04BA06 etilevodopa and decarboxylase inhibitor |
| N04BA07 |
N04BA07 Foslevodopa and decarboxylase inhibitor |
| N04BB |
N04BB Adamantane derivatives |
| N04BB01 |
N04BB01 amantadine |
| N04BC |
N04BC Dopamine agonists |
| N04BC01 |
N04BC01 bromocriptine |
| N04BC02 |
N04BC02 pergolide |
| N04BC03 |
N04BC03 dihydroergocryptine mesylate |
| N04BC04 |
N04BC04 ropinirole |
| N04BC05 |
N04BC05 pramipexole |
| N04BC06 |
N04BC06 cabergoline |
| N04BC07 |
N04BC07 apomorphine |
| N04BC08 |
N04BC08 piribedil |
| N04BC09 |
N04BC09 rotigotine |
| N04BD |
N04BD Monoamine Oxidase B Inhibitors |
| N04BD01 |
N04BD01 selegiline |
| N04BD02 |
N04BD02 rasagiline |
| N04BD03 |
N04BD03 safinamide |
| N04BX |
N04BX Other dopaminergic agents |
| N04BX01 |
N04BX01 tolcapone |
| N04BX02 |
N04BX02 Entacapone |
| N04BX03 |
N04BX03 budipine |
| N04BX04 |
N04BX04 Opicapone |